MUCOSAL HEALING WITH VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: EVIDENCE FROM EARNEST, A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL IN CHRONIC POUCHITIS

Vipul Jairath  ¹     Brian G. Feagan  ²     Mark S. Silverberg  ³     Silvio Danese  ⁴     Paolo Gionchetti  ⁵     Mark Lowenberg  ⁶     Brian Bressler  ⁷     Marc Ferrante  ⁸     Ailsa L Hart  ⁹     Dirk Lindner  ¹⁰     Armella Escher     Stephen Jones     Bo Shen  ¹¹     Simon Travis  ^12    
1 Western University, London, Canada
² Alimentiv Inc., London, Canada
³ Mount Sinai Hospital, Toronto, Canada
⁴ Vita-Salute San Raffaele University - IRCCS San Raffaele Scientific Institute, Milan, Italy
⁵ IRCCS Azienda Ospedaliera-Universitaria di Bologna University of Bologna, Bologna, Italy
⁶ Amsterdam University Medical Center, Amsterdam, Netherlands
⁷ University of British Columbia, Vancouver, Canada
⁸ University Hospitals Leuven, Leuven, Belgium
⁹ St Mark’s Hospital and and Imperial College London, London, United Kingdom
¹⁰ Takeda Pharmaceuticals International AG, Zurich, Switzerland
¹¹ Columbia University Irving Medical Center/Herbert Irving Pavilion, New York, United States
¹² John Radcliffe Hospital, Oxford, United Kingdom

Session
Clinical trials in IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)